Tuesday, March 17, 2026

BLACKPINK Lisa Returns with New Hit ‘New Woman’ Featuring Rosalía

Lisa announced yesterday afternoon that her new song, "NEW WOMAN," will be released on LLOUD Co.'s official website.

North Korea Appoints 4 New Ambassadors, Hinting At Diplomatic Normalization

North Korea has named four new ambassadors within two weeks, marking a significant reshuffle in diplomatic personnel.

North Korea Reports Mining, Chemical, and Agricultural Gains as Workers’ Party Marks 80 Years

North Korea celebrates the Workers' Party's 80th anniversary with economic achievements, loyalty letters, and cultural activities for seniors.

Tag: biosimilar

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

How Celltrion’s Herceptin Biosimilar Herzuma Achieved 74% Market Share in Japan: A Game Changer for Cancer Treatment

Celltrion's Herzuma biosimilar captures 74% of Japan's trastuzumab market, enhancing patient access and leveraging favorable policies.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.